Transcontinental Realty Investors, Inc.
Transcontinental Realty Investors, Inc. (TCI) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Transcontinental Realty Investors, Inc. (TCI), covering cash flow, earnings, and balance sheets.
Transcontinental Realty Investors, Inc. (TCI) Income Statement & Financial Overview
Analyze Transcontinental Realty Investors, Inc.’s TCI earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $12.008M | $11.22M | $11.07M | $11.77M |
| Cost of Revenue | $5.98M | $6.82M | $6.99M | $11.44M |
| Gross Profit | $6.03M | $4.41M | $4.08M | $332000.00 |
| Gross Profit Ratio | $0.50 | $0.39 | $0.37 | $0.03 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.78M | $3.82M | $3.17M | $3.09M |
| Operating Expenses | $6.67M | $6.10M | $5.75M | $5.65M |
| Total Costs & Expenses | $12.64M | $12.91M | $12.74M | $12.86M |
| Interest Income | $4.63M | $4.64M | $5.92M | $5.20M |
| Interest Expense | $1.78M | $1.84M | $2.08M | $1.86M |
| Depreciation & Amortization | $2.90M | $2.87M | $3.32M | $3.14M |
| EBITDA | $2.27M | $1.16M | $7.85M | $7.39M |
| EBITDA Ratio | $0.19 | $0.10 | $0.71 | $0.63 |
| Operating Income | -$635000.00 | -$1.69M | -$1.67M | -$1.08M |
| Operating Income Ratio | -$0.05 | -$0.15 | -$0.15 | -$0.09 |
| Other Income/Expenses (Net) | $6.74M | $2.10M | $2.83M | $3.45M |
| Income Before Tax | $6.10M | $408000.00 | $1.16M | $2.37M |
| Income Before Tax Ratio | $0.51 | $0.04 | $0.10 | $0.20 |
| Income Tax Expense | $1.32M | $112000.00 | -$546000.00 | $669000.00 |
| Net Income | $4.62M | $108000.00 | $1.71M | $1.50M |
| Net Income Ratio | $0.38 | $0.010 | $0.15 | $0.13 |
| EPS | $0.53 | $0.01 | $0.20 | $0.17 |
| Diluted EPS | $0.53 | $0.01 | $0.20 | $0.17 |
| Weighted Avg Shares Outstanding | $8.64M | $8.64M | $8.64M | $8.64M |
| Weighted Avg Shares Outstanding (Diluted) | $8.64M | $8.64M | $8.64M | $8.64M |
The company's financials show resilient growth, with revenue advancing from $11.77M in Q2 2024 to $12.008M in Q1 2025. Gross profit remained healthy with margins at 50% in Q1 2025 compared to 3% in Q2 2024. Operating income hit -$635000.00 last quarter, sustaining a consistent -5% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $2.27M. Net income rose to $4.62M, while earnings per share reached $0.53. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan